Catalyst
Slingshot members are tracking this event:
Kiniksa Pharmaceuticals' (KNSA) Rilonacept in Pericarditis PDUFA date under priority review due March 21, 2021
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| KNSA | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 18, 2021
Occurred Source:
https://investors.kiniksa.com/news-releases/news-release-details/kiniksa-announces-fda-approval-arcalyst-r-rilonacept-recurrent
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Rilonacept, Pericarditis
